Formononetin, a bioactive isoflavone compound in modified nuanxinkang, alleviates cardiorenal syndrome type 4-induced mitochondrial dysfunction by targeting Hippo-YAP signaling
Phytomedicine · 2025-11 · 147 · 157152
DOI: 10.1016/j.phymed.2025.157152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2025-11. Verfasst von Meidan Yao und 13 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, Guangzhou University of Chinese Medicine, No. 16 Airport Road, Baiyun District, Guangzhou 510006, China; Guangzhou Uni…. Hauptthemen laut MEDLINE: Isoflavones, Cardio-Renal Syndrome, Drugs, Chinese Herbal, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Guangzhou Municipal Science and Technology Project.
Abstract (Originalsprache)
BACKGROUND: Cardiorenal syndrome type 4 (CRS4) arises from the chronic kidney disease, and currently, there is a lack of therapies specifically target the dual pathological mechanisms of CRS4, namely mitochondrial dysfunction and maladaptive remodeling. In the present study, our aim was to determine the effectiveness of the herbal formulation modified nuanxinkang (MNXK) and its isoflavone formononetin (FNT) on CRS4. METHODS: CRS4 was modeled in C57BL/6 mice through 5/6 nephrectomy and subsequently treated with MNXK or FNT for 12 weeks, and the cardiac function, histopathology, and mitochondrial ultrastructure were evaluated. To identify the potential targets, network pharmacology, transcriptomics, and molecular dynamic simulations were conducted. Additionally, CRS4 injury was induced in HL-1 cardiomyocytes using uremic serum. RESULTS: MNXK administration significantly improved cardiac function, as evidenced by enhanced ejection fraction, reduced myocardial injury, and restored mitochondrial cristae structure. FNT, the core bioactive component isolated from MNXK, exerted the protective function through directly binding to Yes-associated protein (YAP), thereby blocking nuclear translocation and suppressing the transcription of targets downstream of Hippo pathway. In cardiomyocytes, FNT was demonstrated to attenuate mitochondrial reactive oxygen species (ROS), normalize mitochondrial dynamics, maintain mitochondrial morphology, and thereby enhance mitochondrial function. Additionally, YAP knockdown did not further enhance these beneficial effects. Noticeable, enforced overexpression of YAP abolished FNT-induced cardiac protection. CONCLUSION: Our results demonstrated that MNXK and FNT mitigated CRS4 through activating Hippo-YAP signaling to block pro-fibrotic signal cascades and facilitating mitochondrial rescue via biogenesis and metabolic reprogramming. This study will provide more insights into the treatment of CRS4 with natural small molecule substances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital, Guangzhou University of Chinese Medicine, No. 16 Airport Road, Baiyun District, Guangzhou 510006, China; Guangzhou University of Chinese Medicine, Guangzhou, No. 12 Airport Road, Baiyun Di…
- The First Affiliated Hospital, Guangzhou University of Chinese Medicine, No. 16 Airport Road, Baiyun District, Guangzhou 510006, China.
- Guangzhou University of Chinese Medicine, Guangzhou, No. 12 Airport Road, Baiyun District, Guangzhou 510006, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Guangzhou Municipal Science and Technology Project
Zitieren
APA
Yao, M., Wen, R., Zhuang, H., Li, Y., Lin, X., Pang, S., Zhang, J., Guan, Z., Liang, B., Li, H., Huang, Y., Wang, L., Wang, J., & Dong, X. (2025). Formononetin, a bioactive isoflavone compound in modified nuanxinkang, alleviates cardiorenal syndrome type 4-induced mitochondrial dysfunction by targeting Hippo-YAP signaling. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157152
Vancouver
Yao M, Wen R, Zhuang H, Li Y, Lin X, Pang S, et al. Formononetin, a bioactive isoflavone compound in modified nuanxinkang, alleviates cardiorenal syndrome type 4-induced mitochondrial dysfunction by targeting Hippo-YAP signaling. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157152
BibTeX
@article{Yao2025,
author = {Yao, Meidan and Wen, Ruijia and Zhuang, Haowen and Li, Yihua and Lin, Xiaohua and Pang, Shujin and Zhang, Jingyue and Guan, Zhuoji and Liang, Birong and Li, Huan and Huang, Yusheng and Wang, Lingjun and Wang, Junyan and Dong, Xin},
title = {Formononetin, a bioactive isoflavone compound in modified nuanxinkang, alleviates cardiorenal syndrome type 4-induced mitochondrial dysfunction by targeting Hippo-YAP signaling},
journal = {Phytomedicine},
year = {2025},
doi = {10.1016/j.phymed.2025.157152}
}
EUVIMED